Skip to main content
NCBI home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1987 Jul-Aug;63(6):612–626.

The role of the infectious diseases physician in monitoring antimicrobial use: a pharmacy perspective.

R E Polk
PMCID: PMC1629392  PMID: 3315067

Full text

PDF
612

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramowitz P. W., Nold E. G., Hatfield S. M. Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs. Am J Hosp Pharm. 1982 Jul;39(7):1176–1180. [PubMed] [Google Scholar]
  2. Achong M. R., Wood J., Theal H. K., Goldberg R., Thompson D. A. Changes in hospital antibiotic therapy after a quality-of-use study. Lancet. 1977 Nov 26;2(8048):1118–1122. doi: 10.1016/s0140-6736(77)90558-x. [DOI] [PubMed] [Google Scholar]
  3. Avorn J., Soumerai S. B. A new approach to reducing suboptimal drug use. JAMA. 1983 Oct 7;250(13):1752–1753. [PubMed] [Google Scholar]
  4. Avorn J., Soumerai S. B. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". N Engl J Med. 1983 Jun 16;308(24):1457–1463. doi: 10.1056/NEJM198306163082406. [DOI] [PubMed] [Google Scholar]
  5. Barclay W. R. Prescribing antibiotics: not entirely bad but could be better. JAMA. 1981 Feb 27;245(8):849–849. doi: 10.1001/jama.1981.03310330039022. [DOI] [PubMed] [Google Scholar]
  6. Barriere S. L., Conte J. E., Jr Aminoglycoside use monitored by clinical pharmaceutical services. Am J Hosp Pharm. 1979 Sep;36(9):1209–1211. [PubMed] [Google Scholar]
  7. Buckwold F. J., Ronald A. R. Antimicrobial misuse--effects and suggestions for control. J Antimicrob Chemother. 1979 Mar;5(2):129–136. doi: 10.1093/jac/5.2.129. [DOI] [PubMed] [Google Scholar]
  8. Counts G. W. Review and control of antimicrobial usage in hospitalized patients. A recommended collaborative approach. JAMA. 1977 Nov 14;238(20):2170–2172. [PubMed] [Google Scholar]
  9. Craig W. A., Uman S. J., Shaw W. R., Ramgopal V., Eagan L. L., Leopold E. T. Hospital use of antimicrobial drugs. Survey at 19 hospitals and results of antimicrobial control program. Ann Intern Med. 1978 Nov;89(5 Pt 2 Suppl):793–795. doi: 10.7326/0003-4819-89-5-793. [DOI] [PubMed] [Google Scholar]
  10. DeTorres O. H., White R. E. Effect of aminoglycoside-use restrictions on drug cost. Am J Hosp Pharm. 1984 Jun;41(6):1137–1139. [PubMed] [Google Scholar]
  11. DeVito J. M., John J. F., Jr Effect of formulary restriction of cefotaxime usage. Arch Intern Med. 1985 Jun;145(6):1053–1056. [PubMed] [Google Scholar]
  12. Dillard K. R., Yoshikawa T. T., Guze L. B. Appropriate usage of antibiotics improved by surveillance program. Hospitals. 1977 Oct 1;51(19):81-2, 84-5. [PubMed] [Google Scholar]
  13. Durbin W. A., Jr, Lapidas B., Goldmann D. A. Improved antibiotic usage following introduction of a novel prescription system. JAMA. 1981 Oct 16;246(16):1796–1800. [PubMed] [Google Scholar]
  14. Dzierba S. H., Reilly R. T., Caselnova D. A., 3rd Cost savings achieved through cephalosporin use review and restriction. Am J Hosp Pharm. 1986 Sep;43(9):2194–2197. [PubMed] [Google Scholar]
  15. Echols R. M., Kowalsky S. F. The use of an antibiotic order form for antibiotic utilization review: influence on physicians' prescribing patterns. J Infect Dis. 1984 Dec;150(6):803–807. doi: 10.1093/infdis/150.6.803. [DOI] [PubMed] [Google Scholar]
  16. Egdahl R. H., Taft C. H. Financial incentives to physicians. N Engl J Med. 1986 Jul 3;315(1):59–61. doi: 10.1056/NEJM198607033150111. [DOI] [PubMed] [Google Scholar]
  17. Freedy H. R., Jr, Simonelli R. J. Concurrent monitoring of third generation cephalosporins. Am J Hosp Pharm. 1986 Jan;43(1):140–141. [PubMed] [Google Scholar]
  18. Gilbert D. N., Eubanks N. M., Jackson J. M. The effects of monitoring the use of gentamicin in a community hospital. J Med Educ. 1978 Feb;53(2):129–134. doi: 10.1097/00001888-197802000-00008. [DOI] [PubMed] [Google Scholar]
  19. Greene S. A., Record K. E., Rapp R. P., Amerson A. B., Bell R. M., Piecoro J. J., Jr Pharmacy initiatives to reduce clindamycin use. Am J Hosp Pharm. 1986 May;43(5):1210–1213. [PubMed] [Google Scholar]
  20. Guernsey B. G., Berina L. F., Lazarus M. C., Hokanson J. A., Prohaska C., Allen J. A., Doutre W. H., Mader J. T. Cost containment through therapeutic substitution of aminoglycosides. Hosp Pharm. 1985 Feb;20(2):82-3, 86-92, 95. [PubMed] [Google Scholar]
  21. Hayman J. N., Sbravati E. C. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions. Am J Hosp Pharm. 1985 Jun;42(6):1343–1347. [PubMed] [Google Scholar]
  22. Heineman H. S., Watt V. S. All-inclusive concurrent antibiotic usage review: a way to reduce misuse without formal controls. Infect Control. 1986 Mar;7(3):168–171. doi: 10.1017/s0195941700064018. [DOI] [PubMed] [Google Scholar]
  23. Huber S. L., Patry R. A., Hudson H. D. Influencing drug use through prescribing restrictions. Am J Hosp Pharm. 1982 Nov;39(11):1898–1901. [PubMed] [Google Scholar]
  24. Inaraja M. T., Paloma J. M., Giráldez J., Idoate A. J., Hualde S. Computer-assisted antimicrobial-use monitoring. Am J Hosp Pharm. 1986 Mar;43(3):664–670. [PubMed] [Google Scholar]
  25. Johnson M. W., Mitch W. E., Heller A. H., Spector R. The impact of an educational program on gentamicin use in a teaching hospital. Am J Med. 1982 Jul;73(1):9–14. doi: 10.1016/0002-9343(82)90912-3. [DOI] [PubMed] [Google Scholar]
  26. Jones S. R., Pannell J., Barks J., Yanchick Y. A., Bratton T., Browne R., McRee E., Smith J. W. The effect of an educational program upon hospital antibiotic use. Am J Med Sci. 1977 Jan-Feb;273(1):79–85. doi: 10.1097/00000441-197701000-00008. [DOI] [PubMed] [Google Scholar]
  27. Katz E., Schlamowitz S. Savings achieved through cephalosporin surveillance. Am J Hosp Pharm. 1978 Dec;35(12):1521–1523. [PubMed] [Google Scholar]
  28. Kerns M. P., Meyer G. E. Concurrent antibiotic-use review in a small hospital. Am J Hosp Pharm. 1986 Jun;43(6):1476–1478. [PubMed] [Google Scholar]
  29. Khanderia U. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing. Hosp Formul. 1986 Oct;21(10):1049-50, 1055-6. [PubMed] [Google Scholar]
  30. Kimelblatt B. J., Bradbury K., Chodoff L., Aggour T., Mehl B. Cost-benefit analysis of an aminoglycoside monitoring service. Am J Hosp Pharm. 1986 May;43(5):1205–1209. [PubMed] [Google Scholar]
  31. Klapp D. L., Ramphal R. Antibiotic restriction in hospitals associated with medical schools. Am J Hosp Pharm. 1983 Nov;40(11):1957–1960. [PubMed] [Google Scholar]
  32. Kowalsky S. F., Echols R. M., Peck F., Jr, Lesar T. S., Schwartz M. T. Second-generation antibiotic-order sheet. Am J Hosp Pharm. 1986 May;43(5):1182–1184. [PubMed] [Google Scholar]
  33. Kunin C. M., Chambers S. Responsibility of the infectious disease community for optimal use of antibiotics: views of the membership of the Infectious Diseases Society of America. Rev Infect Dis. 1985 Jul-Aug;7(4):547–559. doi: 10.1093/clinids/7.4.547. [DOI] [PubMed] [Google Scholar]
  34. Kunin C. M. The responsibility of the infectious disease community for the optimal use of antimicrobial agents. J Infect Dis. 1985 Mar;151(3):388–398. doi: 10.1093/infdis/151.3.388. [DOI] [PubMed] [Google Scholar]
  35. Kunin C. M., Tupasi T., Craig W. A. Use of antibiotics. A brief exposition of the problem and some tentative solutions. Ann Intern Med. 1973 Oct;79(4):555–560. doi: 10.7326/0003-4819-79-4-555. [DOI] [PubMed] [Google Scholar]
  36. Latorraca R., Martins R. Surveillance of antibiotics use in a community hospital. JAMA. 1979 Dec 7;242(23):2585–2587. [PubMed] [Google Scholar]
  37. Lawlor M. C., Lucarotti R. L. Clinical pharmacist impact on parenteral cephalosporin prescribing. Hosp Formul. 1983 Apr;18(4):402-4, 407-8. [PubMed] [Google Scholar]
  38. Ma M. Y., Goldstein E. J., Meyer R. D. Effect of control programs on cefazolin prescribing in a teaching hospital. Am J Hosp Pharm. 1979 Aug;36(8):1055–1058. [PubMed] [Google Scholar]
  39. McCloskey W. W., Johnson P. N., Jeffrey L. P. Cephalosporin-use restrictions in teaching hospitals. Am J Hosp Pharm. 1984 Nov;41(11):2359–2362. [PubMed] [Google Scholar]
  40. McCue J. D. P&T Committee guidelines for antibiotic cost comparisons. Hosp Formul. 1986 Jun;21(6):703–706. [PubMed] [Google Scholar]
  41. McGowan J. E., Jr, Finland M. Usage of antibiotics in a general hospital: effect of requiring justification. J Infect Dis. 1974 Aug;130(2):165–168. doi: 10.1093/infdis/130.2.165. [DOI] [PubMed] [Google Scholar]
  42. Moleski R. J., Andriole V. T. Role of the infectious disease specialist in containing costs of antibiotics in the hospital. Rev Infect Dis. 1986 May-Jun;8(3):488–493. doi: 10.1093/clinids/8.3.488. [DOI] [PubMed] [Google Scholar]
  43. Pelletier L. L., Jr Hospital usage of parenteral antimicrobial agents: a gradated utilization review and cost containment program. Infect Control. 1985 Jun;6(6):226–230. doi: 10.1017/s0195941700061579. [DOI] [PubMed] [Google Scholar]
  44. Peterson C. D., Lake K. D. Reducing prophylactic antibiotic costs in cardiovascular surgery: the role of the clinical pharmacist. Drug Intell Clin Pharm. 1986 Feb;20(2):134–137. doi: 10.1177/106002808602000207. [DOI] [PubMed] [Google Scholar]
  45. Recco R. A., Gladstone J. L., Friedman S. A., Gerken E. H. Antibiotic control in a municipal hospital. JAMA. 1979 May 25;241(21):2283–2286. [PubMed] [Google Scholar]
  46. Scarafile P. D., Campbell B. D., Kilroy J. E., Mathewson H. O. Computer-assisted concurrent antibiotic review in a community hospital. Am J Hosp Pharm. 1985 Feb;42(2):313–315. [PubMed] [Google Scholar]
  47. Schaffner W., Ray W. A., Federspiel C. F., Miller W. O. Improving antibiotic prescribing in office practice. A controlled trial of three educational methods. JAMA. 1983 Oct 7;250(13):1728–1732. [PubMed] [Google Scholar]
  48. Schroeder S. A., Myers L. P., McPhee S. J., Showstack J. A., Simborg D. W., Chapman S. A., Leong J. K. The failure of physician education as a cost containment strategy. Report of a prospective controlled trial at a university hospital. JAMA. 1984 Jul 13;252(2):225–230. [PubMed] [Google Scholar]
  49. Schwinghammer T. L., Romano M. J., Wing E. J. Cost savings associated with use of gentamicin versus tobramycin. Am J Hosp Pharm. 1985 Aug;42(8):1745–1749. [PubMed] [Google Scholar]
  50. Seligman S. J. Reduction in antibiotic costs by restricting use of an oral cephalosporin. Am J Med. 1981 Dec;71(6):941–944. doi: 10.1016/0002-9343(81)90304-1. [DOI] [PubMed] [Google Scholar]
  51. Stolar M. H. Model for a formal, prospective antibiotic use review program. Am J Hosp Pharm. 1978 Jul;35(7):809–811. [PubMed] [Google Scholar]
  52. Wein P. J., Hoffman R. P. Promoting the cost-effective utilization of cefoxitin with a drug use education program. Hosp Formul. 1987 Mar;22(3):299–306. [PubMed] [Google Scholar]
  53. Williams R. R., Gross P. A., Levine J. F. Cost containment of the second-generation cephalosporins by prospective monitoring at a community teaching hospital. Arch Intern Med. 1985 Nov;145(11):1978–1981. [PubMed] [Google Scholar]
  54. Witte K. W., Nelson A. A., Jr, Hutchinson R. A. Effect of pharmacist consultation on rational antimicrobial therapy. Am J Hosp Pharm. 1980 Jun;37(6):829–832. [PubMed] [Google Scholar]
  55. Zeman B. T., Pike M., Samet C. The antibiotic utilization committee. Hospitals. 1974 Apr 16;48(8):73–76. [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES